Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)

NCT00478114 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: sorafenib

Sponsor

Mahidol University

Collaborators

[object Object]